Pharmaceutical Technology's In the Lab eNewsletter, December 2021

December 01, 2021

Analytical methods need a boost to ensure quality control for cell and gene therapies.

December 01, 2021

Different methods to calculate limits for impurities will give different answers. The prediction interval method may be ideal.

November 30, 2021

Researchers from MIT have developed novel nanosensors for the detection of the nucleocapsid and spike protein of the SARS-CoV-2 virus.

November 24, 2021

MilliporeSigma’s new ColorWheel flow cytometry portfolio is designed to create antibodies and dyes analogous to a primary conjugated antibody.

November 19, 2021

Sartorius’ newly redesigned vacuum filtration units are designed to allow for faster and higher-capacity filtration while offering enhanced stability for sample processing.

November 18, 2021

Lonza is expanding its microbial development capabilities at its Visp, Switzerland, site to support clinical and commercial drug development programs.

November 16, 2021

Synthace has raised $35 million in funding to fuel growth of its life sciences R&D technology.

November 12, 2021

Fujifilm is expanding its R&D footprint at its California facility.

November 09, 2021

Element’s acquisition of JMI Laboratories will increase their North American service offerings.

November 04, 2021

GenScript’s new gene synthesis center in Piscataway, NJ, is highly automated to accelerate production time and increase supply chain resiliency for biopharma and synthetic biology.

November 04, 2021

Gentronix has expanded it lab facilities and increased capacity for genetic, ocular, and skin toxicology testing.

November 03, 2021

Thermo Fisher Scientific showcases its new mass spectrometry and chromatography solutions at the ASMS Conference on Oct. 31–Nov. 4, 2021.